CompletedPhase 4ACTRN12613000086763

Effective dose of remifentanil for control of hemodynamic response to insertion of the Streamlined Liner of the Pharyngeal Airway(SLIPA)

What is effective dose of remifentanil to control hemodynamic response to insertion of the Streamlined Liner of the Pharyngeal Airway(SLIPA)

Sponsor

Chung-Ang University

Enrollment

100 participants

Start Date

Jan 3, 2011

Study Type

Interventional

Conditions

Hemodynamic response to insertion of the Streamlined Liner of the Pharyngeal Airway(SLIPA)

Summary

A single administration of remifentanil can effectively suppress hemodynamic changes due to the insertion of Streamlined Liner of the Pharyngeal Airway. What is the Effective dose of remifentanil needed to suppress hemodynamic response from Streamlined Liner of the Pharyngeal Airway insertion?

Eligibility

Sex: Both males and femalesMin Age: 20 YearssMax Age: 65 Yearss

Inclusion Criteria1

Patients with healthy and aged 20-65 years old, who were planned general anesthesia.

Exclusion Criteria1

cardiovascular or pulmonary disease, reflux esophagitis, obesity (BMI > 30 kg/m²), or were pregnant, or were addicted to opioids, sedatives, or other medications

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Before insertion of SLIPA, remifentanil (0.5microg/kg, 1.0microg/kg, 1.5microg/kg, 2.0microg/kg ) is injected. there are 4 different intervention groups who receive their allocated dose once only. r

Before insertion of SLIPA, remifentanil (0.5microg/kg, 1.0microg/kg, 1.5microg/kg, 2.0microg/kg ) is injected. there are 4 different intervention groups who receive their allocated dose once only. remifentanil is injected intravenously.

Locations(1)

seoul, Korea, Republic Of

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12613000086763